That would put Anthropic in a more direct fight with OpenAI and Microsoft — not just over model quality, but over the ...
INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing therapies that target innate immune dysfunction, today announced that results from its Phase 2 MINDFuL trial in ...
YIT Corporation Stock Exchange Release 15 May 2026 at 4:15 p.m. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, ...
Hello, and welcome to the Commerzbank AG conference call regarding the first quarter results 2026. Please note that this call is being transmitted as well as recorded by audio webcast and will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results